Sapanisertib,Carboplatin,Paclitaxel
calithera
['paclitaxel', 'sapanisertib', 'carboplatin']
 hot off the press just in time for #aacr23 our investigator initiated study phase i study of mtorc1/2 inhibitor sapanisertib with carboplatin and paclitaxel in mtor pathway altered solid malignancies. we started this concept in 2014 &amp; it's nice to see this 
Oncologist | Associate Prof | Executive Director-Research, MD Anderson Cancer Network | Medical Director, Clinical Center for Targeted Therapy. Tweets = my own.